Compare Hims and Hers Health Inc (HIMS) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Vital Farms Inc — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Hims and Hers Health Inc is far larger — about 16.2× Vital Farms Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Vital Farms Inc for 14 Days on average.
| HIMS | VITL | |
|---|---|---|
Market Cap | $6.55B | $405.27M |
Volume | 14,842,814 | 1,810,837 |
Sector | Health | Consumer Staples |
52-Week High | $62.76 | $43.68 |
52-Week Low | $14.52 | $8.28 |
Typical Hold Time | 21 Days | 14 Days |
Enterprise Value | $7.25B | $492.28M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.
The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.
Vital Farms (VITL) trades at $9.33, showing modest daily gains but facing significant fundamental challenges. The company reported declining revenue and profitability in 2026, with net income margin collapsing to 0.02% from 8.72% in 2025. Technical indicators show bearish momentum, while analyst sentiment remains cautiously optimistic with a $13.11 consensus target. Recent news highlights strategic review possibilities and institutional accumulation despite operational headwinds.
The outlook remains challenging with pricing pressure and supply issues affecting margins, though strategic options exploration provides potential upside. Investment opportunity exists if operational improvements materialize, but risks include sustained margin compression and execution challenges in a competitive egg market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
